Bibliography
- WANG PY, SCHINAZI RF, CHU CK: Asymmetric synthesis and anti-H1V activity of 1 -carbo cyclic 2',3t-didehydro-2',3t-dideoxyadenosine. Bioorg. Med. Chem. Lett. (1998) 8:1585–1588.
- MARTINEZ LE, NUGENT WA, JACOBSEN EN: Highly efficient and enantioselective synthesis of carbocyclic nucleoside analogs using selective early transition metal catalysis. J. Org. Chem. (1996) 61:7963–7966.
- CRIMMINIS MT, KING BW: An efficient asymmetric approach to carbocyclic nucleosides: asymmetric synthesis of 1259U89, a potent inhibitor of I-11Yr everse transcriptase. J. Org. Chem. (1996) 61:192–193.
- CAMPBELL J, LEE WK, RAPOPORT H: Chirospecific synthesis and precursors of cyclopentene and cyclopentene carbocyclic nucleosides by [3+3]-coupling and transannular alkylation. J. Org. Chem. (1995) 60:4602–4616.
- HORWITZ JP, CHUA J, DA ROOGE MA, NOEL M, KLUNDT IL: Nucleosides. IX. The formation of 2',3'-unsaturated pyrimidine nucleosides via a novel 13-elimination reaction. J. Org. Chem. (1996) 31:205–211.
- MCGUIGAN C, TSANG HVV, CAHARD D et al.: Phosphora-midate derivatives of D4T as inhibitors of HIV: the effect of amino acid variation. J. Med. Chem. (1996) 39:1748–1753.
- MCGUIGAN C, CHARD D, SHEEKA HM, DE CLERCQ E, BALZARINI J: Aryl phosphoramidate derivatives of D4T have improved anti-HIV efficacy in tissue culture and may act by the generation of a novel intracellular metabolite. Antiviral Res. (1997) 35:195–204.
- BALZARINI J, WEDGWOOD 0, KRUINING J et al.: Anti-HIV and an ti-HBV activity and resistance profile of 2',3'-dideoxy-3t-thiacytidine (3TC) and its arylphos-phoramidate derivative CF 1109. Biochem. Biophys. Res. Commun. (1996) 225:363–369.
- AVERETT DR: Anti-HIV compound assessment by two novel high-capacity assays. J. Virol. Methods (1989) 23:263–276.
- JANSEN RW, JOHANSON LC, AVERETT DR: High-capacityin vitroassessment of anti-hepatitis-B virus compound selectivity by a virion-specific polymerase chain-reaction assay. Antimicrob. Agents Chemother. (1993) 37:441–447.